Larry Todd Edwards
Chief Commercial Officer; Reporting Person's title: EVP Chief Commercial Officer; Reporting Person's title: EVP, Chief Commercial Officer · 3 filings · Latest: Aug 24, 2026
Arcutis Biotherapeutics, Inc.
Oruka Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARQT | Larry Todd Edwards | — | Sep 16, 2026 | Proposed Sale | $25.00 | 341,980 | $8.5M | — | |
ARQT | Larry Todd Edwards | Reporting Person's title: EVP, Chief Commercial Officer | Mar 2, 2026 | Sale | $25.18 | 3,687 | $92.8K | 175,178 | |
ARQT | Larry Todd Edwards | — | Mar 2, 2026 | Proposed Sale | $25.18 | 3,687 | $92.8K | — | |
ARQT | Larry Todd Edwards | Reporting Person's title: EVP Chief Commercial Officer | Feb 2, 2026 | Sale | $25.50 | 2,052 | $52.3K | 148,865 | |
ARQT | Todd Edwards | — | Feb 2, 2026 | Proposed Sale | $25.50 | 2,052 | $52.3K | — | |
ARQT | Todd Edwards | — | Nov 6, 2025 | Proposed Sale | $25.16 | 29,131 | $732.9K | — | Nov 6 9:54 PM 144/A |
AVTR | Todd Edwards | — | Nov 6, 2025 | Proposed Sale | $25.16 | 29,131 | $732.9K | — | |
ARQT | Larry Todd Edwards | — | Oct 2, 2025 | Proposed Sale | $20.04 | 4,504 | $90.3K | — | |
ARQT | Edwards Larry Todd | — | May 19, 2025 | Proposed Sale | $14.07 | 7,451 | $104.8K | — | |
ARQT | Edwards Larry Todd | — | Feb 3, 2025 | Proposed Sale | $12.70 | 2,173 | $27.6K | — | |
ARQT | Edwards Larry Todd | — | Oct 2, 2024 | Proposed Sale | $10.01 | 3,725 | $37.3K | — |